Company / R&D Expense
SOLIGENIX, INC. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$5.2M
FY2025
5-year range
$3.3M / $9.8M
FY2021-FY2025
Trend
+57.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense returned to growth in FY2025 after 3 years of decline, reaching $5M.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of -8.5%.
Declined from $8M to $5M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -13.9%
- 5-Year CAGR
- -8.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -8.5%, indicating a declining trend.
- In FY2025, r&d expense increased 57.7% year-over-year.
- Peak r&d expense was recorded in FY2021.
- Lowest r&d expense in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.2M | +57.7% |
| FY2024 | $3.3M | -58.3% |
| FY2023 | $7.9M | -3.0% |
| FY2022 | $8.2M | -16.4% |
| FY2021 | $9.8M | +20.6% |
| FY2020 | $8.1M | +20.3% |
| FY2019 | $6.8M | +22.6% |
| FY2018 | $5.5M | +28.2% |
| FY2017 | $4.3M | -20.4% |
| FY2016 | $5.4M | +6.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026